SCHEMBL9680281

SCHEMBL9680281

O=C(OCc1ccccc1)N(c1ccccc1)c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.55
TDP1 Q9NUW8 3/20 0.53
L3MBTL1 Q9Y468 2/20 0.53
KMT2A Q03164 2/20 0.53
MAPK1 P28482 1/20 0.53
ATM Q13315 1/20 0.53
SLC6A2 P23975 1/20 0.53
SLC6A3 Q01959 1/20 0.53
MAPT P10636 1/20 0.50
HPGD P15428 1/20 0.50
CHRM2 P08172 1/20 0.49
CHRM5 P08912 1/20 0.49
CHRM1 P11229 1/20 0.49
CHRM3 P20309 1/20 0.49
LMNA P02545 2/20 0.49
HCAR2 Q8TDS4 1/20 0.49
NPSR1 Q6W5P4 2/20 0.48
CCR6 P51684 1/20 0.48
PAX8 Q06710 1/20 0.48
PTGIR P43119 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7105658 0.87 OPRK1 (0.45) ALDH1A1TDP1L3MBTL1KMT2AMAPK1
SCHEMBL7105650 0.85 TDP1 (0.44) ALDH1A1TDP1L3MBTL1KMT2AMAPK1
SCHEMBL9135166 0.85 ALDH1A1 (0.52) ALDH1A1TDP1L3MBTL1KMT2AMAPK1
SCHEMBL9118903 0.85 ALDH1A1 (0.55) ALDH1A1TDP1L3MBTL1KMT2AMAPK1
SCHEMBL17092997 0.85 ATM (0.53) ALDH1A1TDP1L3MBTL1KMT2AATM
SCHEMBL24729148 0.84 ALDH1A1 (0.44) ALDH1A1TDP1L3MBTL1KMT2AMAPK1
SCHEMBL12606466 0.84 PTGIR (0.49) ALDH1A1TDP1L3MBTL1KMT2AMAPK1
SCHEMBL7288194 0.83 ALDH1A1 (0.53) ALDH1A1TDP1L3MBTL1KMT2AMAPK1
SCHEMBL24729192 0.83 ALDH1A1 (0.56) ALDH1A1TDP1L3MBTL1KMT2AMAPK1
SCHEMBL16964891 0.82 TDP1 (0.59) ALDH1A1TDP1L3MBTL1KMT2AATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5153226-A Administering as anticholesterol agents, for atherosclerosis WARNER-LAMBERT COMPANY (US) 1992-10-06 US disclosed
EP-0415413-A1 Acat inhibitors WARNER-LAMBERT COMPANY (US) 1991-03-06 EP disclosed